Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$117.73
-0.43%
Mkt Cap $7.02B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $192.89M | $197.91M | +2.60% | $0.44 | $0.49 | +11.36% | — | — |
| Q4 2025 Oct 28, 2025 | $192.23M | $188.81M | -1.78% | $0.42 | $0.46 | +9.52% | — | — |
| Q3 2025 Jul 29, 2025 | $181.82M | $182.37M | +0.30% | $0.40 | $0.37 | -7.50% | — | — |
| Q2 2025 Apr 29, 2025 | $173.57M | $169.17M | -2.53% | $0.35 | $0.39 | +11.43% | — | — |
| Q1 2025 Feb 20, 2025 | $164.09M | $167.55M | +2.11% | $0.41 | $0.44 | +7.32% | — | — |
| Q4 2024 Nov 12, 2024 | $153.02M | $154.87M | +1.21% | $0.34 | $0.43 | +28.21% | — | — |
| Q3 2024 Jul 30, 2024 | $154.12M | $154.07M | -0.03% | $0.33 | $0.33 | +0.00% | — | — |
| Q2 2024 May 1, 2024 | $150.06M | $151.35M | +0.86% | $0.29 | $0.28 | -3.45% | — | — |
| Q1 2024 Feb 21, 2024 | $155.39M | $155.74M | +0.23% | $0.34 | $0.33 | -2.94% | — | — |
| Q4 2023 Oct 31, 2023 | $140.64M | $141.19M | +0.39% | $0.14 | $0.23 | +64.29% | — | — |
| Q3 2023 Aug 2, 2023 | $165.92M | $159.17M | -4.07% | $0.49 | $0.53 | +8.16% | — | — |
| Q2 2023 May 2, 2023 | $181.43M | $182.66M | +0.68% | $0.59 | $0.64 | +8.47% | — | — |
| Q1 2023 Feb 22, 2023 | $184.55M | $186.76M | +1.20% | $0.58 | $0.68 | +17.24% | — | — |
| Q4 2022 Nov 1, 2022 | $191.50M | $200.74M | +4.83% | $0.68 | $0.77 | +13.24% | — | — |
| Q3 2022 Aug 2, 2022 | $189.06M | $207.63M | +9.82% | $0.72 | $0.91 | +26.39% | — | — |
| Q2 2022 Apr 27, 2022 | $185.48M | $206.40M | +11.28% | $0.72 | $0.92 | +27.78% | — | — |
| Q1 2022 Feb 17, 2022 | $179.27M | $186.52M | +4.05% | $0.65 | $0.81 | +24.62% | — | — |
| Q4 2021 Oct 28, 2021 | $163.97M | $178.22M | +8.69% | $0.64 | $0.78 | +21.88% | — | — |
| Q3 2021 Jul 27, 2021 | $163.97M | $162.96M | -0.62% | $0.52 | $0.79 | +51.92% | — | — |
| Q2 2021 May 4, 2021 | $117.87M | $142.84M | +21.18% | $0.42 | $0.68 | +61.90% | — | — |